BindingDB logo
myBDB logout

BDBM332479 4-(6-(5-bromooxazol-2-yl)-1-(2-chloro-6-(trifluoromethyl)benzoyl)-1H-indazol-3-yl)-3-fluorobenzoic acid::US10196354, Example 18B::US9745265, 18B

SMILES: OC(=O)c1ccc(-c2nn(C(=O)c3c(Cl)cccc3C(F)(F)F)c3cc(ccc23)-c2ncc(Br)o2)c(F)c1

InChI Key: InChIKey=FBJVFVUDDUPHAU-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 332479   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Nuclear receptor ROR-gamma


(Mus musculus)
BDBM332479
PNG
(4-(6-(5-bromooxazol-2-yl)-1-(2-chloro-6-(trifluoro...)
Show SMILES OC(=O)c1ccc(-c2nn(C(=O)c3c(Cl)cccc3C(F)(F)F)c3cc(ccc23)-c2ncc(Br)o2)c(F)c1
Show InChI InChI=1S/C25H11BrClF4N3O4/c26-19-10-32-22(38-19)11-4-7-14-18(9-11)34(23(35)20-15(25(29,30)31)2-1-3-16(20)27)33-21(14)13-6-5-12(24(36)37)8-17(13)28/h1-10H,(H,36,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 26n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...


US Patent US9745265 (2017)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma


(Homo sapiens (Human))
BDBM332479
PNG
(4-(6-(5-bromooxazol-2-yl)-1-(2-chloro-6-(trifluoro...)
Show SMILES OC(=O)c1ccc(-c2nn(C(=O)c3c(Cl)cccc3C(F)(F)F)c3cc(ccc23)-c2ncc(Br)o2)c(F)c1
Show InChI InChI=1S/C25H11BrClF4N3O4/c26-19-10-32-22(38-19)11-4-7-14-18(9-11)34(23(35)20-15(25(29,30)31)2-1-3-16(20)27)33-21(14)13-6-5-12(24(36)37)8-17(13)28/h1-10H,(H,36,37)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 26n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...


US Patent US10196354 (2019)

More data for this
Ligand-Target Pair